Zhong Yuan Bio-Technology Holdings Limited

OTCPK:ZHYB.F Stock Report

Market Cap: US$35.4m

Zhong Yuan Bio-Technology Holdings Management

Management criteria checks 3/4

Zhong Yuan Bio-Technology Holdings' CEO is Tina Chang, appointed in May 2017, has a tenure of 7.67 years. total yearly compensation is $16.78K, comprised of 100% salary and 0% bonuses, including company stock and options. directly owns 51.28% of the company’s shares, worth $18.16M. The average tenure of the management team and the board of directors is 7.7 years and 2.4 years respectively.

Key information

Tina Chang

Chief executive officer

US$16.8k

Total compensation

CEO salary percentage100.0%
CEO tenure7.7yrs
CEO ownership51.3%
Management average tenure7.7yrs
Board average tenure2.4yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Tina Chang's remuneration changed compared to Zhong Yuan Bio-Technology Holdings's earnings?
DateTotal CompensationSalaryCompany Earnings
Mar 31 2024US$17kUS$17k

US$302k

Dec 31 2023n/an/a

US$40k

Sep 30 2023n/an/a

-US$303k

Jun 30 2023n/an/a

-US$1m

Mar 31 2023US$18kUS$18k

-US$2m

Sep 30 2022n/an/a

-US$1m

Jun 30 2022n/an/a

-US$837k

Mar 31 2022US$19kUS$19k

-US$683k

Dec 31 2021n/an/a

-US$443k

Sep 30 2021n/an/a

-US$40k

Jun 30 2021n/an/a

-US$34k

Mar 31 2021US$18kUS$18k

-US$28k

Dec 31 2020n/an/a

-US$230k

Sep 30 2020n/an/a

-US$432k

Jun 30 2020n/an/a

-US$260k

Mar 31 2020US$18kUS$18k

-US$87k

Dec 31 2019n/an/a

US$24k

Sep 30 2019n/an/a

US$135k

Jun 30 2019n/an/a

US$208k

Mar 31 2019US$18kUS$18k

US$280k

Dec 31 2018US$18kUS$18k

-US$46k

Compensation vs Market: Tina's total compensation ($USD16.78K) is below average for companies of similar size in the US market ($USD645.47K).

Compensation vs Earnings: Tina's compensation has been consistent with company performance over the past year.


CEO

Tina Chang (34 yo)

7.7yrs

Tenure

US$16,776

Compensation

Ms. Ting Ting Chang, also known as Tina, has been President, Chief Executive Officer, Secretary and Director at Zhong Yuan Bio-Technology Holdings Limited since May 4, 2017 and also served as its Chief Fin...


Leadership Team

NamePositionTenureCompensationOwnership
Ting Ting Chang
President7.7yrsUS$16.78k51.28%
$ 18.2m
Fung Ming Pang
CFO & Director4.7yrsUS$72.00k16.54%
$ 5.9m
Xianyang Chen
Chief Technical Officer of Bao Feng9yrsno data12%
$ 4.3m
Yu Gao
Chief Marketing Officer of Bao Fengno dataUS$16.78kno data

7.7yrs

Average Tenure

40yo

Average Age

Experienced Management: ZHYB.F's management team is seasoned and experienced (7.7 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Ting Ting Chang
President7.7yrsUS$16.78k51.28%
$ 18.2m
Fung Ming Pang
CFO & Director4.7yrsUS$72.00k16.54%
$ 5.9m
Chi Wai Tse
Independent Non-Executive Director2.4yrsUS$24.00kno data
Shuo Dong
Independent Non-Executive Director2.4yrsUS$24.00kno data
Chinghai Ning
Independent Non-Executive Director1.6yrsUS$19.00kno data

2.4yrs

Average Tenure

54yo

Average Age

Experienced Board: ZHYB.F's board of directors are not considered experienced ( 2.4 years average tenure), which suggests a new board.


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/11 16:04
End of Day Share Price 2024/12/27 00:00
Earnings2024/03/31
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Zhong Yuan Bio-Technology Holdings Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution